Duodenal Neoplasms
|
group |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
3
|
|
0.010 |
None |
1.000 |
1 |
|
2002 |
2002 |
Visual Pathway Glioma
|
disease |
Neoplasms
|
Neoplastic Process
|
10
|
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Non-metastatic prostate cancer
|
disease |
Neoplasms; Male Urogenital Diseases
|
Neoplastic Process
|
18
|
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Agoraphobia
|
disease |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
29
|
11
|
0.010 |
None |
< 0.001 |
1 |
|
2014 |
2014 |
Uterine Neoplasms
|
group |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications
|
Neoplastic Process
|
32
|
1
|
0.010 |
None |
1.000 |
1 |
|
2005 |
2005 |
Age-Related Memory Disorders
|
group |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases; Behavior and Behavior Mechanisms
|
Mental or Behavioral Dysfunction
|
43
|
|
0.300 |
None |
1.000 |
1 |
|
2007 |
2007 |
Memory Disorder, Semantic
|
phenotype |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases; Behavior and Behavior Mechanisms
|
Mental or Behavioral Dysfunction
|
43
|
|
0.300 |
None |
1.000 |
1 |
|
2007 |
2007 |
Memory Disorder, Spatial
|
phenotype |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases; Behavior and Behavior Mechanisms
|
Mental or Behavioral Dysfunction
|
43
|
|
0.300 |
None |
1.000 |
1 |
|
2007 |
2007 |
Gastrinoma
|
disease |
Digestive System Diseases; Neoplasms; Endocrine System Diseases
|
Neoplastic Process
|
49
|
|
0.020 |
None |
1.000 |
2 |
|
1996 |
2018 |
Prostate cancer recurrent
|
disease |
Neoplasms; Male Urogenital Diseases
|
Neoplastic Process
|
54
|
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Seasonal Affective Disorder
|
disease |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
57
|
17
|
0.010 |
None |
1.000 |
1 |
|
2010 |
2010 |
Memory Disorders
|
disease |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases; Behavior and Behavior Mechanisms
|
Mental or Behavioral Dysfunction
|
62
|
|
0.300 |
None |
1.000 |
1 |
|
2007 |
2007 |
Primary Lesion
|
phenotype |
|
Disease or Syndrome
|
71
|
8
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Metastatic castration-resistant prostate cancer
|
disease |
|
Neoplastic Process
|
140
|
2
|
0.010 |
None |
1.000 |
1 |
|
2020 |
2020 |
Memory Loss
|
phenotype |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases; Behavior and Behavior Mechanisms
|
Sign or Symptom
|
163
|
10
|
0.300 |
None |
1.000 |
1 |
|
2007 |
2007 |
Panic Disorder
|
disease |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
175
|
101
|
0.030 |
None |
0.667 |
3 |
|
2009 |
2014 |
Gastrointestinal Neoplasms
|
group |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
182
|
3
|
0.010 |
None |
1.000 |
1 |
|
2008 |
2008 |
Kidney Calculi
|
disease |
Pathological Conditions, Signs and Symptoms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Disease or Syndrome
|
190
|
71
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
PACHYONYCHIA CONGENITA 3
|
disease |
|
Disease or Syndrome
|
209
|
20
|
0.040 |
None |
1.000 |
4 |
|
2009 |
2019 |
Nephrolithiasis
|
disease |
Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Disease or Syndrome
|
242
|
99
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Metastatic Prostate Carcinoma
|
disease |
Neoplasms; Male Urogenital Diseases
|
Neoplastic Process
|
362
|
24
|
0.010 |
None |
1.000 |
1 |
|
2009 |
2009 |
Adenocarcinoma of colon
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
406
|
10
|
0.010 |
None |
1.000 |
1 |
|
2003 |
2003 |
Oestrogen receptor positive breast cancer
|
disease |
|
Neoplastic Process
|
510
|
58
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Drug-Induced Liver Disease
|
phenotype |
Digestive System Diseases; Chemically-Induced Disorders
|
Disease or Syndrome
|
537
|
29
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Anaplasia
|
disease |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
538
|
7
|
0.010 |
None |
1.000 |
1 |
|
2003 |
2003 |